Cytotoxin

CD123 Interaction

CD123 Interactions

Histiocytic Disorders, Malignant

<section class="Section" data-sectioncode="34089-3"><a name="s_1100"></a><a name="section-8"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Tagraxofusp-erzs, a CD123-directed cytotoxin, is a fusion protein comprised of a recombinant human interleukin-3 (IL-3) and truncated diphtheria toxin (DT). Tagraxofusp-erzs has an approximate molecular weight of 57,695 Daltons. Tagraxofusp-erzs is constructed by recombinant DNA technology and produced in <span class="Italics">Escherichia coli</span> cells.</p><p>ELZONRIS (tagraxofusp-erzs) injection is a preservative-free, sterile, clear, colorless solution that may contain a few white to translucent particles and requires dilution prior to intravenous infusion. ELZONRIS is supplied at a concentration of 1,000 mcg/mL in a single-dose vial. Each mL of ELZONRIS contains 1,000 mcg tagraxofusp-erzs, sodium chloride (4.38 mg), sorbitol (50 mg), tromethamine (2.42 mg) and Water for Injection, USP and pH is 7.5.</p></section>

Elzonris

tagraxofusp-erzs

tagraxofusp

1 ML tagraxofusp-erzs 1 MG/ML Injection

1 ML tagraxofusp-erzs 1 MG/ML Injection [Elzonris]

Psoriasis (PsO)

Psoriatic Arthritis (PsA)

Ankylosing Spondylitis (AS)

Nonradiographic Axial Spondyloarthritis

Taltz

Juvenile Idiopathic Arthritis

Hidradenitis Suppurativa (HS)

Cosentyx

Siliq

Tremfya

Crohn's Disease (CD)

Ulcerative Colitis (UC)

Stelara

Skyrizi

Ilumya

Migraine

Cluster Headache

Migraine Prevention

Emgality

Qulipta

Acute Migraine

Ubrelvy

Nurtec ODT

Vyepti

Aimovig

Ajovy

Breast Cancer: HR+ (HER2-)

Verzenio

Ibrance

Kisqali

Atopic Dermatitis (Eczema)

Cibinqo

Eucrisa

Asthma (injectable)

Asthma OCS Dependent

Nasal Polyposis

Eosinophilic Esophagitis (EoE)

Prurigo Nodularis

Dupixent

Opzelura

Adbry

NSCLC ALK+ OR ROS1+ Disease

Lorbrena

Alecensa

Alunbrig

NSCLC cMET Mutation

Xalkori

Rheumatoid Arthritis (RA)

Xeljanz

Uveitis

Graft Versus Host Disease (GVHD)

Orencia

COVID-19 Treatment

Alopecia Areata

Olumiant

Multiple Sclerosis (MS)

Secondary Progressive Multiple Sclerosis

Zeposia

Rinvoq

Entyvio

Report Adverse Event 

Prescribing Information

Pharmacy List 

Reimbursement Information

Billing & Coding Guide 

Stemline ARC Enrollment Form 

Coverage Authorization Request 

Coverage Authorization Appeals 

Letter of Medical Necessity 

Enroll in Patient Savings Program

Stemline Patient Assistance Program

Other HCP Resources 

Elzonris Treatment Guide 

Treatment Tracker 

Patient Information Card 

Stemline ARC Patient Brochure 

About Elzonris 

Receiving Elzonris 

Side Effects 

Patient Resources 

ARC Patient Advocates

Instructions For Use: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)